Page results
-
Cerebral palsy (CP) is a permanent disorder affecting movement in different parts of the body often accompanied by disturbances of sensation, cognition, communication, perception, behaviour and musculoskeletal problems.
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Patient information for patients suffering from long COVID who are returning to work.
-
This page provides information for patients following a Gastric Bypass/Sleeve Gastrectomy.
-
Join in our reflective heart Christmas 2020 campaign! Every year, supporters, staff and friends of UCLH Charity write a message of thanks, celebration or remembrance on a reflective heart together with a donation.
-
Care in the last days of life: information for families, friends and carers.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
File results
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0357 - Multiple myeloma treatments